Rajagopal Aravalli

Prof. Rajagopal Aravalli

University of Minnesota
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2008 in Hepatology
Verified
Journal Article
Closed access
PDF file
RARajagopal Aravalli
Rajagopal Aravalli
CSClifford J. Steer
Clifford J. Steer
ECErik N. K. Cressman
Erik N. K. Cressman

25 September 2012 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
RARajagopal Aravalli
Rajagopal Aravalli
ECErik N. K. Cressman
Erik N. K. Cressman
CSClifford J. Steer
Clifford J. Steer

1 January 2013 in World Journal of Gastroenterology
Verified
Journal Article
Open access
RARajagopal Aravalli
Rajagopal Aravalli
Hepatocellular carcinoma (HCC) is the most common form of liver cancer worldwide. It is caused by a variety of risk factors, most common ones being infection with hepatitis viruses, alcohol, and obesity. HCC often develops in the background of underlying cirrhosis, and even though a number of interventional treatment methods are currently in use, recurrence is fairly common among patients who have had a resection. Therefore, whole liver transplantation remains the most practical treatment option for HCC. Due to the growing incidence of HCC, intense research efforts are being made to understand cellular and molecular mechanisms of the disease so that novel therapeutic strategies can be developed to combat liver cancer. In recent years, it has become clear that innate immunity plays a critical role in the development of a number of liver diseases, including HCC. In particular, the activation of Toll-like receptor signaling results in the generation of immune responses that often results in the production of pro-inflammatory cytokines and chemokines, and could cause acute inflammation in the liver. In this review, the current knowledge on the role of innate immune responses in the development and progression of HCC is examined, and emerging therapeutic strategies based on molecular mechanisms of HCC are discussed.

30 April 2007 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
RARajagopal Aravalli
Rajagopal Aravalli
SHShuxian Hu
Shuxian Hu
JLJames R Lokensgard
James R Lokensgard
Background: Information regarding the response of brain cells to infection with herpes simplex virus (HSV)-1 is needed for a complete understanding of viral neuropathogenesis. We have recently demonstrated that microglial cells respond to HSV infection by producing a number of proinflammatory cytokines and chemokines through a mechanism involving Toll-like receptor 2 (TLR2). Following this cytokine burst, microglial cells rapidly undergo cell death by apoptosis. We hypothesized that TLR2 signaling might mediate the cell death process as well.Methods: To test this hypothesis, we investigated HSV-induced cell death of microglia obtained from both wild-type and TLR2-/-mice. Cell death was studied by oligonucleosomal ELISA and TUNEL staining, and the mechanisms of apoptosis were further analyzed using murine apoptosis-specific microarrays. The data obtained from microarray analysis were then validated using quantitative real-time PCR assays.Results: HSV infection induced apoptotic cell death in microglial cells from wild-type as well as TLR2 cells. However, the cell death at 24 h p.i. was markedly lower in knockout cells. Furthermore, microarray analyses clearly showed that the expression of pro-apoptotic genes was down-regulated at the time when wild-type cells were actively undergoing apoptosis, indicating a differential response to HSV in cells with or without TLR2.Conclusion: We demonstrate here that HSV induces an apoptotic response in microglial cells which is mediated through TLR2 signaling.

1 December 2012 in The Veterinary Journal
Verified
Journal Article
Closed access
RARajagopal Aravalli
Rajagopal Aravalli
ECErik N.K. Cressman
Erik N.K. Cressman
CSClifford J. Steer
Clifford J. Steer

26 May 2015 in Liver Transplantation
Verified
Journal Article
Closed access
RARajagopal Aravalli
Rajagopal Aravalli
JBJohn D. Belcher
John D. Belcher
Clifford John SteerClifford John Steer
Clifford John Steer